Walid Fayad

1.8k total citations
57 papers, 1.4k citations indexed

About

Walid Fayad is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Walid Fayad has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Organic Chemistry and 12 papers in Pharmacology. Recurrent topics in Walid Fayad's work include Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (6 papers). Walid Fayad is often cited by papers focused on Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (6 papers). Walid Fayad collaborates with scholars based in Egypt, United States and Sweden. Walid Fayad's co-authors include Stig Linder, Maria Hägg Olofsson, Rolf Larsson, Mårten Fryknäs, May A. El‐Manawaty, Salwa M. El‐Hallouty, Tamer Nasr, Linda Rickardson, B. El-Menshawi and Siva S. Panda and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Walid Fayad

54 papers receiving 1.4k citations

Peers

Walid Fayad

ONCOL

PHARM

Martin Kello Slovakia

Gul-e-Saba Chaudhry Malaysia

Yamei Yu China

Stanton Kok Hong Kong

Ahmed Abdrabou Egypt

Claire M. Pfeffer United States

Vilma Petrikaitė Lithuania

Fatemeh Mosaffa Iran

Divyashree Ravishankar United Kingdom

Nadiah Abu Malaysia

Martin Kello Slovakia

Walid Fayad

779 ×1.4

311 ×0.7

190 ×0.9

ONCOL

177 ×1.1

PHARM

184 ×1.2

Citations per year, relative to Walid Fayad Walid Fayad (= 1×) peers Martin Kello

Countries citing papers authored by Walid Fayad

Since Specialization

Citations

This map shows the geographic impact of Walid Fayad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Fayad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Fayad more than expected).

Fields of papers citing papers by Walid Fayad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Fayad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Fayad. The network helps show where Walid Fayad may publish in the future.

Co-authorship network of co-authors of Walid Fayad

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Fayad. A scholar is included among the top collaborators of Walid Fayad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Fayad. Walid Fayad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahmoud, Khaled, et al.. (2025). Assessment of cytotoxicity of some synthetic compounds against breast carcinoma spheroids with subsequent analysis of pro-apoptotic and gene expression. Scientific Reports. 15(1). 42543–42543.

Youssef, Mohamed A., Siva S. Panda, Benson M. Kariuki, et al.. (2025). Design and synthesis of antiproliferative 2-oxoindolin-3-ylidenes incorporating urea function with potential VEGFR-2 inhibitory properties. Scientific Reports. 15(1). 618–618.

Farid, Alyaa, et al.. (2024). Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals. 17(7). 922–922. 8 indexed citations

Nasr, Soad M., et al.. (2024). Anti-inflammatory potential of aspergillus unguis SP51-EGY: TLR4-dependent effects & chemical diversity via Q-TOF LC-HRMS. BMC Biotechnology. 24(1). 62–62. 1 indexed citations

Panda, Siva S., Adel S. Girgis, Mona F. Said, et al.. (2022). Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies. ChemMedChem. 17(13). e202200164–e202200164. 15 indexed citations

Amin, Maha M., et al.. (2022). “TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells”. International Journal of Pharmaceutics. 619. 121717–121717. 44 indexed citations

Youssef, Mohamed A., Siva S. Panda, Riham A. El‐Shiekh, et al.. (2020). Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]. RSC Advances. 10(37). 21830–21838. 15 indexed citations

Elkhateeb, Waill A., Ghoson M. Daba, Walid Fayad, et al.. (2019). GC-MS analysis and in-vitro hypocholesterolemic, anti-rotavirus, anti-human colon carcinoma activities of the crude extract of a Japanese Ganoderma spp. Stirling Online Research Repository (University of Stirling). 6 indexed citations

Panda, Siva S., Adel S. Girgis, Tarek S. Ibrahim, et al.. (2019). Fluoroquinolone-3-carboxamide Amino Acid Conjugates: Synthesis, Antibacterial Properties And Molecular Modeling Studies. Medicinal Chemistry. 17(1). 71–84. 6 indexed citations

10.

Panda, Siva S., Adel S. Girgis, Bibhuti B. Mishra, et al.. (2019). Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid–isoniazid hybrid conjugates. RSC Advances. 9(35). 20450–20462. 16 indexed citations

11.

Panda, Siva S., Adel S. Girgis, Riham F. George, et al.. (2019). Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone–dichloroacetic acid hybrids. Chemical Biology & Drug Design. 95(2). 248–259. 15 indexed citations

12.

Panda, Siva S., et al.. (2019). Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics. RSC Advances. 9(58). 33761–33774. 17 indexed citations

13.

Nasr, Tamer, Samir Bondock, Hassan M. Rashed, et al.. (2018). Novel hydrazide-hydrazone and amide substituted coumarin derivatives: Synthesis, cytotoxicity screening, microarray, radiolabeling and in vivo pharmacokinetic studies. European Journal of Medicinal Chemistry. 151. 723–739. 67 indexed citations

14.

Nasr, Tamer, Samir Bondock, Mаhmoud Youns, Walid Fayad, & Wafaa A. Zaghary. (2017). Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4- d ][1,2,3]triazine derivatives. European Journal of Medicinal Chemistry. 141. 603–614. 25 indexed citations

15.

El-Hady, Faten K. Abd, et al.. (2016). Investigating on the Correlation Between Some Biological Activities of Marine Sponge-Associated Bacteria Extracts and Isolated Diketopiperazines. Current Microbiology. 74(1). 6–13. 11 indexed citations

16.

Fayad, Walid, et al.. (2015). Evaluation of anticancer activity of some Egyptian plants showed free radical scavenging activity.. International Journal of PharmTech Research. 8(3). 387–393. 6 indexed citations

17.

Nada, Ahmed A., Ahmed Hassabo, Walid Fayad, et al.. (2015). Biomaterials Based on Essential Fatty Acids and Carbohydrates for Chronic Wounds. Journal of Applied Pharmaceutical Science. 13–21. 43 indexed citations

18.

Yousif, Fouad, Loutfy Boulos, Khaled Mahmoud, et al.. (2011). Contribution toin vitroscreening of Egyptian plants for schistosomicidal activity. Pharmaceutical Biology. 50(6). 732–739. 29 indexed citations

19.

Hassan, Saadia, Haile Mahteme, Jenny Felth, et al.. (2011). Novel activity of acriflavine against colorectal cancer tumor cells. Cancer Science. 102(12). 2206–2213. 54 indexed citations

20.

Fayad, Walid, Linda Rickardson, Caroline Haglund, et al.. (2011). Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties. Chemical Biology & Drug Design. 78(4). 547–557. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact